Trial aims to shrink tough rectal tumors with aggressive chemo cocktail
NCT ID NCT03997435
Summary
This study is testing if adding a more intensive chemotherapy combination (called FOLFOXIRI) to the standard pre-surgery treatment can better shrink aggressive rectal tumors. It involves 72 adults with high-risk, locally advanced rectal cancer that hasn't spread to distant organs. The main goal is to see if this intensified approach leads to more patients having no detectable cancer left in their surgical specimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Queen Mary Hospital
Hong Kong, Hong Kong
-
Department of Oncology, Princess Margaret Hospital
Hong Kong, Hong Kong
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.